Bharatrohan Airborne Innovations has achieved internal technology milestone in applying its proprietary hyperspectral imaging platform to pharmaceutical quality screening. In controlled proof-of-concept testing, the company's imaging system demonstrated the ability to non-destructively differentiate genuine pharmaceutical tablets from adulterated or substandard samples by capturing and analysing spectral signatures across the visible and near-infrared portions of the spectrum.
This represents an extension of the company's existing hyperspectral imaging expertise, developed and commercially deployed in precision agriculture, into pharmaceutical quality assurance and anticounterfeiting, opening a new addressable market for the company. The company is currently engaged in discussions with multiple regulatory and scientific authorities in India's pharmaceutical quality ecosystem to explore pathways for validating and potentially piloting this technology.
Bharatrohan Airborne Innovations is engaged in an emerging business model, distinguishing itself as an agritech and agri value chain solutions provider. It leverages drone/UAV based platforms, with a main focus on Hyperspectral Imaging (HSI) technology.
